Jiangsu, China

Na Ye

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Na Ye. Retrieved from https://idiyas.com/inventor/na-ye-72fwzj3g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Na Ye - Innovator in Fendiline Derivatives

Introduction

Na Ye is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of medicinal chemistry, particularly through her work on fendiline derivatives. Her innovative approach has led to the development of novel compounds that hold potential therapeutic applications.

Latest Patents

Na Ye holds a patent for her invention related to fendiline derivatives. This patent, which includes 1 patent, focuses on the preparation and use of these novel compounds, specifically outlined in Formula I and Formula II. The invention aims to enhance the efficacy and safety of fendiline derivatives in medical applications.

Career Highlights

Na Ye is affiliated with the University of Texas System, where she conducts her research and development activities. Her work has garnered attention for its potential impact on drug development and therapeutic strategies. She is recognized for her dedication to advancing scientific knowledge in her field.

Collaborations

Na Ye collaborates with esteemed colleagues, including Jeffrey A. Frost and Jia Zhou. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in medicinal chemistry.

Conclusion

Na Ye's contributions to the field of fendiline derivatives exemplify her commitment to innovation and research. Her work not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…